David R. Mc Avoy is Gen Counsel, CCO, & Secretary of Brickell Biotech, Inc.. Currently has a direct ownership of 16,061 shares of BBI, which is worth approximately $28,267. The most recent transaction as insider was on Oct 02, 2023, when has been sold 7,358 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $7,210. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.1K
0% 3M change
0% 12M change
Total Value Held $28,267

David R. McAvoy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2023
SELL
Payment of exercise price or tax liability
$7,210 $0.98 p/Share
7,358 Reduced 31.42%
16,061 Common Stock
Oct 02 2023
BUY
Exercise of conversion of derivative security
-
20,000 Added 46.06%
23,419 Common Stock
Jul 23 2021
BUY
Open market or private purchase
$12,143 $0.67 p/Share
18,124 Added 12.33%
128,879 Common Stock
May 17 2021
BUY
Open market or private purchase
$14,898 $0.8 p/Share
18,622 Added 14.39%
110,755 Common Stock
Mar 16 2021
SELL
Payment of exercise price or tax liability
$9,975 $1.14 p/Share
8,750 Reduced 8.67%
92,133 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
-
25,000 Added 19.86%
100,883 Common Stock

Also insider at

TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare
DRM

David R. Mc Avoy

Gen Counsel, CCO, & Secretary
Boulder, CO

Track Institutional and Insider Activities on BBI

Follow Brickell Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBI shares.

Notify only if

Insider Trading

Get notified when an Brickell Biotech, Inc. insider buys or sells BBI shares.

Notify only if

News

Receive news related to Brickell Biotech, Inc.

Track Activities on BBI